Metraipolis › archive › dc_ab3ac2832a2f

Efficacy and Safety of Finerenone in Patients Aged 65 Years or Older with Diabetic Kidney Disease: Subgroup Analysis of the FINDKDLATAM Study — Europe PMC PMID:42512859

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42512859
DOI
10.3390/medicina62071317
License (as archived)
solo-consultazione
Archived
2026-10-18T09:55:31.987Z
SHA-256 of the archived text
9eaf84effeea6e8c68d898c0e59d1577baa15a3e38bd6ea723fc6d6f6d342ca0
Stable URL of this page
https://metraipolis.com/documento/dc_ab3ac2832a2f

How to cite

Efficacy and Safety of Finerenone in Patients Aged 65 Years or Older with Diabetic Kidney Disease: Subgroup Analysis of the FINDKDLATAM Study — Europe PMC PMID:42512859 — Europe PMC (en), https://europepmc.org/article/MED/42512859 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ab3ac2832a2f (Metraipolis archive dc_ab3ac2832a2f, sha256 9eaf84effeea6e8c68d898c0e59d1577baa15a3e38bd6ea723fc6d6f6d342ca0)
BibTeX
@misc{dcab3ac2832a2f,
  title = {Efficacy and Safety of Finerenone in Patients Aged 65 Years or Older with Diabetic Kidney Disease: Subgroup Analysis of the FINDKDLATAM Study — Europe PMC PMID:42512859},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42512859},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ab3ac2832a2f; sha256 9eaf84effeea6e8c68d898c0e59d1577baa15a3e38bd6ea723fc6d6f6d342ca0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42512859. Agents can read the archived copy with the MCP tool read_document.